1Papeix C, Vidal JS, de seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica [J]. Mult Scler, 2007, 13(2): 256-259.
2Wingerchuk DM, Lennon VA, Pittock S J, et al. Rivised diagnostic criteria for neuromyelitis optica [J]. Neurology, 2006, 66 (10): 1485-1489.
3Lennon VA, Kryer T J, Pittock S J, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water chamlel[J]. J Exp Med, 2005, 202(4): 473-477.
4Lennon VA, Wingerchuck DM, Kryer T J, et al. A serum autoantibody mark of neuromyelitis optiea: distinction from multiple sclerosis[J]. Lancet, 2004, 364(9451): 2106-2112.
5Misu T, Fujihara K, Nakashima I, et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica [J]. Neurology, 2005, 65(9): 1479-1482.
6Milano E, Disapi A, Malucchi S, et al. Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse [J]. Neurol Sci, 2003, 24(3): 130-133.
7Bergamaschi R, Tonietti S, Franciotta D, et al.Oligclonal bands in Devic's neuromyelitis optica and multiple sclerosis:differences in repeated cerebrospinal fluid examinations[J]. Mult Scler, 2004, 10 (I): 2-4.
8de Seze J, Lebrun C, Stojkovic T, et al. Is devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis[J]. Mult Scler, 2003, 9(5): 521-522.
9Misu T, Fujihara K, Nakaslaima I, et al. Pure opticspinal form of multiple sclerosis in Japan[J]. Brain, 2002, 125(Pt 11): 2460-2468.
10Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin-4 in lesions of neuromyelitis optica: distinction from multiple sclerosis [J]. Brain, 2007, 130(Pt 5): 1224-1234.
